#Balajiamines Q3 22 Concall Highlights 🧪🧪
Like & Retweet for better reach !
Operational Highlights
1. Revenues stood at ₹475 Cr in Q3FY22 compared to ₹366 Cr in Q3FY21, growth of 29.4% YoY
2. EBITDA stood at 109.3 Cr translating 23% EBITDA margins
Like & Retweet for better reach !
Operational Highlights
1. Revenues stood at ₹475 Cr in Q3FY22 compared to ₹366 Cr in Q3FY21, growth of 29.4% YoY
2. EBITDA stood at 109.3 Cr translating 23% EBITDA margins
3. Sales volumes were down by 13.77% from 31,993 MT in Q3FY21 to 27,589 MT in Q3FY22. As few of the clients couldn’t procure Key Starting Materials (KSMs) to match the products.
4. Despite sluggish demand for few of the products and shut down of acetonitrile and DMF plants for debottlenecking which were completed in the month of November 2021, the revenues showed a decent growth of 44% which stood at ₹556 Cr in Q3FY22
5. Volume contribution
Amines- 6,460 MT
Amines Derivatives- 9,912 MT
Specialty Chemicals-11,217 MT
Capacity utilisation stood at 52% in 9MFY22
6. Procurement of raw material are key challenge for FY23
Amines- 6,460 MT
Amines Derivatives- 9,912 MT
Specialty Chemicals-11,217 MT
Capacity utilisation stood at 52% in 9MFY22
6. Procurement of raw material are key challenge for FY23
7. DMC is used in the production of Polycarbonate and Lithium Batteries – the consumption of which will exponentially grow in India backed by government incentives
8. Pharmaceutical application segment and agrochemicals are expected to drive significant demand for Methylamines and related value-added products
Subsidiary- (Balaji Specialty Chemicals Private Ltd)
Unavailability of key raw materials resulted in contraction of production. However, from the month of January the supply bottlenecks have eased, and expect to operate the subsidiary plant
Unavailability of key raw materials resulted in contraction of production. However, from the month of January the supply bottlenecks have eased, and expect to operate the subsidiary plant
at 70-80% capacity and achieve annual turnover of about ₹475 - ₹500 crore in the next fiscal year
Capex
Acetonitrile
1. Ramp up in production from 9 tons per day to 13 tons per day due to debottlenecking.
Capex
Acetonitrile
1. Ramp up in production from 9 tons per day to 13 tons per day due to debottlenecking.
2. Plan to undertake further capex for additional Acetonitrile plant having capacity of 50 TPD and plant is likely to commence operations by FY24.
Di-Methyl Carbonate
1. The project is on track and expect to commence during Q1FY23
2. Confident on achieving capacity utilisation of 60-70% first year of
Operations
Methylamines
Plan to set up a separate plant for Methylamines with capacity of
1. The project is on track and expect to commence during Q1FY23
2. Confident on achieving capacity utilisation of 60-70% first year of
Operations
Methylamines
Plan to set up a separate plant for Methylamines with capacity of
40,000 to 50,000 TPA under Phase-2 expansion of Greenfield Project
The environmental clearance is already received.
Dimethyl Formamide
Plan to set up a separate plant for DMF with a capacity of 30,000 TPA under phase-2 expansion of Greenfield Project
The environmental clearance is already received.
Dimethyl Formamide
Plan to set up a separate plant for DMF with a capacity of 30,000 TPA under phase-2 expansion of Greenfield Project
• • •
Missing some Tweet in this thread? You can try to
force a refresh
